Imiti ya TFF gukora inama yimari muri Q2 2022

FORT WORTH, TX, 2 Kanama 2022 (GLOBE NEWSWIRE) - TFF Pharmaceuticals, Inc. , uyumunsi yatangaje ko izashyira ahagaragara igihembwe cyayo cya kabiri 2022 ibisubizo byimari no gusuzuma ubucuruzi kuwa kane.Ku ya 11 Kanama 2022, igihe isoko ry’imari ry’Amerika ryarangiraga.
Ubuyobozi buzakora inama ihamagara saa yine nigice za mugitondo ET kugirango baganire kubisubizo byubukungu no gutanga amakuru ajyanye niterambere ryamasosiyete nubuvuzi.Ikiganiro kizakurikirwa na Q&A isomo hamwe nabashoramari.
Isosiyete izahamagara inama ku wa kane, 11 Kanama 2022 saa yine n'igice za mugitondo ET kugirango isuzume imikorere y’amavuriro, ibigo ndetse n’imari.Kwinjira mu nama, injira kuri webcast cyangwa uhamagare kimwe muri ibi bikurikira mbere yo gutangira guhamagara:
Ihamagarwa kandi rizaba imbuga za interineti kandi urashobora kuboneka kurubuga rwa TFF Pharmaceuticals, https://tffpharma.com cyangwa kuri https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Ihamagarwa kandi rizaba imbuga za interineti kandi urashobora kuboneka kurubuga rwa TFF Pharmaceuticals, https://tffpharma.com cyangwa kuri https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Конг также будет କାନлироваться в прямом эфире и доступна на гит-сайтте TFF Pharmaceuticals https://tffpharma.com или непосредственно на https://viavid.webcasts.com/starthere.jsp?ei=1558943&tp_key Iyi nama kandi izanyuzwa kumurongo kandi iboneka kurubuga rwa TFF Pharmaceuticals https://tffpharma.com cyangwa kuri https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.电话 会议 还将 进行 网络 直播 , 可以 在 Imiti ya TFF FF 网站 https://tffpharma.com 或 直接 访问 https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47 访问。 Imiti ya TFF 的 网站 https://tffpharma.com 或 直接 访问 https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key34=43 Конференц-связь также будет କାନлироваться в Интернете и доступна на ки-сайте TFF Pharmaceuticals по ауу https://tffpharma.com или напрямую по пиуу https://viavid.webcasts.com/starthere.jsp?e43 = 4559 Ihamagarwa ry'inama kandi rizaba ku rubuga rwa interineti kandi riboneka ku rubuga rwa TFF Pharmaceuticals kuri https://tffpharma.com cyangwa kuri https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.Nyamuneka sura urubuga rwisosiyete byibura iminota 15 mbere yuko usabwa kwiyandikisha, gukuramo no kwinjizamo porogaramu zose zikenewe.Ihamagarwa kandi rizakinwa ukwezi kose mugice cya Kalendari y abashoramari kurubuga rwisosiyete.
Kubijyanye na TFF FARMACEUTICALS Yoroheje ya tekinoroji ya tekinoroji ya tekinoroji ya TFF Pharmaceuticals yemewe na tekinoroji ya Thin Film Freezing (TFF) ituma ibice bihari hamwe n’imiti mishya bihinduka ifu yumye yumutungo wihariye hamwe ninyungu zidasanzwe.Igikorwa cyo gukonjesha firime nigikorwa cyubwubatsi bugenewe kubyara ifu yumye ifite ibintu byiza byo guhumeka, kubabyeyi, izuru, umunwa, ibyingenzi nubuvuzi bwamaso yubuyobozi.Iyi nzira irashobora gukoreshwa mugutezimbere ifu kugirango itangwe neza kurubuga rwifuzwa, bityo wirinde ibibazo byubuyobozi bwa sisitemu no kunoza bioavailability, gutangira ibikorwa byihuse, no guteza imbere umutekano no gukora neza.Ubushobozi bwo gutanga ubuvuzi butaziguye ku ngingo zigenewe nk'ibihaha bituma ifu ya TFF itangwa ku kigero cyo hasi ugereranije no mu kanwa, kugabanya uburozi budakenewe n'ingaruka mbi.Imibare ya laboratoire yerekana ko imiterere yindege ya porojeri yoroheje ikonje ishobora gutanga kugeza 75% byikinini cyinjira mubihaha.Aho guhura nubushyuhe, guhagarika umutima, cyangwa izindi mbaraga zishobora kwangiza ibintu byinshi bigoye kuvura nkibinyabuzima byoroshye, gukonjesha firime yoroheje bituma ibyo bikoresho bihinduka ifu yumye byoroshye kubika nubushyuhe buhamye, bigatuma imiti ninkingo bihinduka. gukwirakwizwa cyane ku isi..Ibyiza byo gukonjesha firime yoroheje birashobora gukoreshwa mugutezimbere imigenzo gakondo cyangwa hamwe na farumasi yigihe kizaza.
KUBYEREKEYE TFF PHARMACEUTICALS TFF Pharmaceuticals, Inc.Isosiyete ikora ibijyanye n’ikoranabuhanga rya Thin Film Freezing (TFF) ifite porogaramu nini kandi ihindura imiti iyo ari yo yose, harimo inkingo, molekile nto nini nini, na biologiya, ihinduka ifu yumye yoroshye guhumeka kandi ikinjira neza, bityo ibiyobyabwenge na byo birashobora kuba yatanzwe.mumaso, izuru nuruhu rwaho.TFF ifite abakandida babiri b’ibiyobyabwenge by’amavuriro, ifu yo guhumeka ya voriconazole hamwe nifu ya tacrolimus ihumeka, kandi ikomeje kwagura ibikorwa byayo kugirango ihindure ubuzima bw’isi yose ikorana n’amasosiyete atandukanye y’imiti, ibigo by’ubumenyi n’abafatanyabikorwa ba leta.Ihuriro rya TFF rikubiyemo patenti zirenga 120 zatanzwe cyangwa zitegereje muri Amerika no mu bindi bihugu.Kugira ngo umenye byinshi kuri Pharmaceuticals ya TFF n'ibicuruzwa byayo, nyamuneka sura urubuga rw'isosiyete kuri https://tffpharma.com.
Safe Harbour Iri tangazo rigenewe abanyamakuru ririmo kureba imbere yerekeye TFF Pharmaceuticals, Inc. .Aya magambo-areba imbere arimo ingaruka zizwi kandi zitazwi, kutamenya neza nibindi bintu bishobora gutera ibisubizo nyabyo gutandukana mubintu.Muri ibyo bintu harimo: (i) ibyago isosiyete idashobora kurangiza neza ibizamini byubuvuzi cyangwa kwemererwa mbere na mbere na tacrolimus ihumeka, ifu ya voriconazole, cyangwa umwe mubakandida ba poro yumye, (ii) kubura urutonde rwa ibiyobyabwenge kurubuga rwa TFF byemerewe mbere na FDA cyangwa ubundi buryo bwo gutondekanya imiti yubucuruzi, (iii) isosiyete ntago igirana amasezerano cyangwa ubwumvikane nisosiyete ikomeye yimiti ikora imiti kugirango ishyirwe mubikorwa bya TFF, (iv) isosiyete ntizashobora kugirana amasezerano yigihe kirekire yubucuruzi nundi muntu wa gatatu;na (v) izindi ngaruka zagaragaye mu gice cyitwa “Risk Factors” igice cya Ifishi ya 10 ya Raporo y’umwaka wa 2021 y’isosiyete - K, yashyikirijwe SEC ku ya 24 Werurwe 2022. Pharmaceuticals ya TFF iraburira abasomyi kudashingira ku kintu icyo ari cyo cyose cyangwa imbere- kureba ibisobanuro.Imiti ya TFF ifata kandi ikamagana byimazeyo inshingano zose zo kuvugurura cyangwa kuvugurura ayo magambo kugirango yerekane ibihe bishya cyangwa ibihe bitunguranye, keretse nkuko amategeko abiteganya.
TFF Pharmaceuticals Investor Relations Contact: Corey Davis, PhD LifeSci Advisorsscdavis@lifesciadvisors.com 212-915-2577
TFF Pharmaceuticals Media Contact: Gwendolyn SchankerLifeSci Communications(269) 921-3607gschanker@lifescicomms.com


Igihe cyo kohereza: Kanama-10-2022